ANI Pharmaceuticals, Inc. (ANIP)

NASDAQ: ANIP · Real-Time Price · USD

75.76

-2.49 (-3.18%)

At close: Aug 10, 2026, 4:00 PM EDT

76.76

+1.00 (1.32%)

After-hours: Aug 10, 2026, 7:46 PM EDT

ANI Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	978.38	883.37	614.38	486.82	316.39	216.14
Revenue Growth	30.90%	43.78%	26.20%	53.87%	46.38%	3.67%
Gross Profit	590.98	542.06	364.17	305.3	177.6	115.53
Operating Income	150.36	111.09	0.58	46.97	-35.28	-39.79
Net Income	108.31	77.18	-18.52	18.78	-47.9	-42.6
Earnings Per Share	4.64	3.32	-1.04	0.85	-3.05	-3.40
EPS Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Generics and Other	412.06	399.43	320.03	289.31	235.24
Rare Disease and Brands	566.32	483.93	294.34	197.5	81.15
Total	978.38	883.37	614.38	486.82	316.39

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	375.84	294.72	151.17	221.12	48.23	100.3
Total Debt	610.49	617.04	624.09	285.67	286.52	287.35
Net Cash (Debt)	-234.66	-322.32	-472.92	-64.55	-238.29	-187.05
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-11.00	-15.18	-24.48	-3.55	-14.66	-14.93

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	170.72	64.02	118.96	-31.2	3.32	15.27
Capital Expenditures	-14.99	-16.24	-8.87	-8.88	-2.56	-6.14
Free Cash Flow	155.73	47.78	110.09	-40.08	0.77	9.13
Free Cash Flow Growth	102.84%	-56.60%	-	-	-91.62%	-76.58%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	60.40%	61.36%	59.27%	62.71%	56.13%	53.45%
Operating Margin	15.37%	12.58%	0.10%	9.65%	-11.15%	-18.41%
Pretax Margin	14.57%	10.84%	-3.62%	4.08%	-19.81%	-25.94%
Profit Margin	11.07%	8.87%	-3.01%	3.86%	-15.14%	-19.71%
FCF Margin	0.00%	0.00%	7.78%	22.61%	-12.67%	0.35%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	16.69	23.78	-	64.87	-	-
Forward PE	7.99	10.03	10.72	14.04	14.79	12.86
P/FCF Ratio	9.38	-	24.42	10.25	-	1013.74
PS Ratio	1.66	2.01	1.90	2.32	2.22	3.59